American Express Co vs Vertex Pharmaceuticals Incorporated — how do they compare? American Express Co trades at $340.59 (market cap $230.15B), while Vertex Pharmaceuticals Incorporated trades at $529.62 (market cap $134.25B). The key difference: American Express Co is the larger of the two by market cap, and American Express Co pays a 1.11% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| AXP | VRTX | |
|---|---|---|
Market Cap | $230.15B | $134.25B |
Sector | Financials | Health |
52-Week High | $384.82 | $529.65 |
52-Week Low | $292.27 | $376.62 |
Dividend Yield | 1.11% | — |
Enterprise Value | — | $128.37B |
Trailing returns across standard periods
Latest headlines on both assets
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →